Since hitting the scene, GLP-1 drugs such as Ozempic and Wegovy have taken Tinseltown by storm, with A-listers looking thinner than they have in decades. The Post caught up with the infamous ...

Fetterman, a democrat from Pennsylvania, said this week that he started using weight loss drug Mounjaro, a competitor to Ozempic, last summer. Though the 6-foot-8 senator lost 20 pounds on the ...

A MOTHER has revealed that she lost over seven stone after using Ozempic for 12 months. Hannah, who is from the United States, claimed that people told her not to use the fat jabs because of their ...

Research out this week might help you plan your own version of the Ozempic diet, with the results of a survey revealing the foods that people tend to avoid, or eat less of, once they start taking ...

Ozempic, a chainsaw, divorce papers and a live turtle were among the unique things people have left behind in Ubers across the country, according to the ride sharing platform's report, released ...

Share on Pinterest Common antidiabetes drugs could help lower Alzheimer’s risk, increasing evidence suggests. Image credit: mbbirdy/Getty Images. A new study investigates the relationship ...

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may significantly reduce the risk of dementia, particularly in individuals with type 2 ...

After Trainor shared a snapshot of her new figure on Instagram, an online critic cattily commented: "Ozempic is crazy." Noted diet guru Dr. Stuart Fischer, who has not treated Trainor, said he ...

There were some weird things left in Ubers last year — and nowhere were passengers more forgetful than in New York City, new data shows. Newark, New Jersey, wasn't far behind, at eighth on the ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the ...

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...

Novo Nordisk (NYSE:NVO)) is going big in Brazil. The drugmaker behind Ozempic and Wegovy just dropped a $1.09 billion investment to supercharge its manufacturing plant in Montes Claros.